Concepedia

Daniela Prox

DP

Statistics

Publications

5

Citations

388

H-Index

5

Active since

2001

Affiliations

Boston Children's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

AstraZeneca (United Kingdom)

Daniela Prox is an author at Boston Children's Hospital specializing in cancer pharmacology, medicine, and oncology.

Publications per year

2001–2011

5

Publications

5

Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.

O. Kisker, C.-M. Becker, Daniela Prox et al. · PubMed · 2001 · 258 citations

, , +9

Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium

Paul Beaudry, Monique B. Nilsson, Matthew J. Rioth et al. · Molecular Cancer Therapeutics · 2008 · 44 citations

, , +17

Treatment of Human Pancreatic Cancer in Mice with Angiogenic Inhibitors

Daniela Prox, Christian M. Becker, Steven Pirie‐Shepherd et al. · World Journal of Surgery · 2003 · 38 citations

, , +12

Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib

Carmen M. Barnés, Daniela Prox, Hau D. Le et al. · Pediatric Research · 2011 · 27 citations

, , +13

Sensitivity of NSCLC cell lines bearing wild type and mutated EGFR to the VEGF/EGFR inhibitor ZD6474

Alexandra Briggs, Danielle Molofsky, Andrew Z. Wang et al. · 2005 · 21 citations

, , +16

1–5 of 5